PharmacoEconomics & Outcomes News

, Volume 821, Issue 1, pp 11–11 | Cite as

Considerable economic burden of MenB in Germany

Clinical study


  1. Scholz S, et al. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine : 18 Jan 2019. Available from: URL: Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations